And so Monday is over. Hope yours was as interesting as ours. Now, though, the time has come to catch up on sundry tasks - recycling, for instance, must be carted off the Pharmalot corporate campus this evening - and we hope to indulge later with a good book. See you all in the morning...
Schering-Plough Asthma Inhaler Approved For Children (Yahoo/AP)
Glaxo Vaccine May Prevent Recurrence Of Lung Cancer After Surgery (The Telegraph)
Three Pfizer Employees In Nigerian Court In Trovan Case (Agence France Presse)
1 Comment
As I am unlikely to ever work for Schering, I can't imagine the circumstance under which I would feel comfortable using any inhaled product manufactured by them. I certainly hope the SBA for this product is stronger than the one for Proventil HFA considering I still don't understand an approval (even for a new formulation) with those reviewer comments.